| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Dambkowski Carl serves as a Chief Medical Officer at APGE. Across recent SEC filings that breaks down to 0 buys and 43 sells. Those positions are worth an estimated $23.5M at current prices.
Historically, Dambkowski Carl's trades have earned a below-average insider score of 47/100 across 20 rated trades. Over a 12-month horizon, 28.6% of those trades were profitable, with an average 12-month return of -47.9%.
The biggest single holding is APGE (~$23.5M) as Chief Medical Officer. The recent filings there lean toward selling, a net 161,470 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2024 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 6,665 | $47.56 | $316,969.44 | -1.2% | -1.5% | -20.9% | |
| Aug 7, 2024 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 7,335 | $40.67 | $298,335.79 | -0.8% | +42.6% | -11.9% | |
| Jul 3, 2024 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 5,995 | $37.60 | $225,417.96 | -1.0% | +52.8% | +26.6% |